Effect of topical antioxidant therapy on experimental infectious keratitis
- PMID: 7743801
Effect of topical antioxidant therapy on experimental infectious keratitis
Abstract
To test the effect that the treatment with topical antioxidants may have on corneal infection, we have studied the effect of topically applied antioxidants, such as dimethylthiourea 0.5% (DMTU) and dismutase superoxide 0.2% (SOD), on infectious experimental keratitis caused by Staphylococcus aureus. We have quantified the results of the incubated corneas in ex vivo as well as in in vivo treated with antioxidants by using the luminol amplified chemiluminescence technique (LAC). The evaluation of corneal inflammation was performed calculating the average inflammatory index obtained from the clinical observation of the corneal secretion, corneal edema and ciliary injection. The evolution of the corneal infiltration was evaluated by means of computerized planymetry. The antioxidants used in this study demonstrated a significant reduction of the LAC values when compared with a control group both in the in vivo as well as in ex vivo studies. No significant differences in the clinical evaluation of the average inflammatory index were observed between the study and the control groups. However, a significant increase in the corneal infiltration was registered in the antioxidant treated group (p < 0.001) evaluated by computerized planymetry. Our results indicate that the use of antioxidants as antiinflammatory drugs may have a potential negative influence on the course of infectious keratitis.
Similar articles
-
Antioxidant therapy in the treatment of experimental acute corneal inflammation.Ophthalmic Res. 1995;27(3):136-43. doi: 10.1159/000267648. Ophthalmic Res. 1995. PMID: 8538990
-
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.Curr Eye Res. 2005 Mar;30(3):155-61. doi: 10.1080/02713680490908733. Curr Eye Res. 2005. PMID: 15804740
-
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.J Ocul Pharmacol Ther. 2007 Jun;23(3):213-20. doi: 10.1089/jop.2006.81. J Ocul Pharmacol Ther. 2007. PMID: 17593004
-
Pharmacokinetic considerations in the treatment of bacterial keratitis.Clin Pharmacokinet. 1994 Aug;27(2):129-49. doi: 10.2165/00003088-199427020-00005. Clin Pharmacokinet. 1994. PMID: 7955776 Review.
-
Indecision about corticosteroids for bacterial keratitis: an evidence-based update.Ophthalmology. 2002 May;109(5):835-42; quiz 843. doi: 10.1016/s0161-6420(02)00963-6. Ophthalmology. 2002. PMID: 11986084 Review.
Cited by
-
Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells.Mol Vis. 2011 Feb 18;17:533-42. Mol Vis. 2011. PMID: 21364905 Free PMC article.
-
Oxidative stress induced age dependent meibomian gland dysfunction in Cu, Zn-superoxide dismutase-1 (Sod1) knockout mice.PLoS One. 2014 Jul 18;9(7):e99328. doi: 10.1371/journal.pone.0099328. eCollection 2014. PLoS One. 2014. PMID: 25036096 Free PMC article.
-
Evaluation of lipid oxidative stress status and inflammation in atopic ocular surface disease.Mol Vis. 2010 Nov 19;16:2465-75. Mol Vis. 2010. PMID: 21139696 Free PMC article.
-
Current perspectives on ophthalmic mycoses.Clin Microbiol Rev. 2003 Oct;16(4):730-97. doi: 10.1128/CMR.16.4.730-797.2003. Clin Microbiol Rev. 2003. PMID: 14557297 Free PMC article. Review.
-
Emerging Strategies in Treating Corneal Alkali Burns: A Narrative Review.Cureus. 2023 Oct 25;15(10):e47662. doi: 10.7759/cureus.47662. eCollection 2023 Oct. Cureus. 2023. PMID: 38021904 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical